Ben Kolisnyk

CEO at Bough Biosciences

Presenter

Dr. Kolisnyk is a scientist and biotech founder passionate about developing transformative treatments for brain disorders. His work bridges cutting-edge biology and drug development, with a focus on targeting senescent cells, a key driver of neurodegeneration and psychiatric disease.

He holds a PhD in Neurobiology and has spent his career at the intersection of neuroscience and biotech. Before founding the company in 2023, he conducted postdoctoral research in molecular and cellular neuroscience and worked at a leading biotech, where he helped translate early-stage science into therapeutic strategies.